If a colorectal tumour displays molecular features suggestive of LS, a diagnosis of LS is confirmed by the identification of a germline pathogenic variant in MLH1, MSH2, MSH6, PMS2 or EPCAM [6, 9]. This evidence concerns the gene PMS2 and Leigh syndrome.